Fiera Capital (Canada)’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Fiera Capital (Canada)’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-47,279	Closed	-$4.98M	–	789
2016 Q4	$4.98M	Buy	47,279 +16,059	+51%	+$1.68M	0.03%	315
2016 Q3	$3.45M	Sell	31,220 -1,819	-6%	-$241K	0.02%	367
2016 Q2	$4.81M	Sell	33,039 -1,261	-4%	-$179K	0.03%	332
2016 Q1	$4.91M	Buy	+34,300	New	+$4.87M	0.04%	184
2015 Q2	–	Sell	-43,600	Closed	-$6.15M	–	554
2015 Q1	$6.15M	Buy	43,600 +6,300	+17%	+$970K	0.05%	198
2014 Q4	$5.53M	Buy	37,300 +4,800	+15%	+$705K	0.04%	188
2014 Q3	$5M	Buy	32,500 +2,200	+7%	+$331K	0.04%	218
2014 Q2	$4.25M	Buy	30,300 +4,200	+16%	+$466K	0.02%	253
2014 Q1	$2.9M	Buy	+26,100	New	+$2.84M	0.02%	281

Other funds holding TARO

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Fiera Capital (Canada)'s TARO Position: Q1 2017 in Review

Fiera Capital (Canada) sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q1 2017, closing a stake of 47,279 shares — an estimated $4.98M sold.

Fiera Capital (Canada) first reported a position in TARO in Q1 2014 and held it in 9 quarters. The position peaked at $6.15M in Q1 2015. 139 funds tracked by Wall St. Rank hold TARO as of Q1 2017.

Fiera Capital (Canada) reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q1 2017 after selling out during the quarter.
Fiera Capital (Canada) sold 47,279 Taro Pharmaceutical Industries Ltd. shares in Q1 2017, an estimated $4.98M.
Fiera Capital (Canada) first reported a position in Taro Pharmaceutical Industries Ltd. in Q1 2014 and held it in 9 quarters.
Fiera Capital (Canada)'s Taro Pharmaceutical Industries Ltd. position peaked at $6.15M in Q1 2015.
139 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q1 2017.

Based on Fiera Capital (Canada)'s 13F filing for Q1 2017, filed 15 May 2017.